Trial Profile
Phase III trial of iguratimod compared to sulfasalazine in patients with rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Iguratimod (Primary) ; Sulfasalazine
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.